熱門資訊> 正文
Plus Therapeutics宣布1比25反向股票分割
2026-03-31 19:53
- Plus Therapeutics (PSTV) on Tuesday announced a reverse stock split of its shares of common stock at a ratio of 1-for-25.
- The reverse stock split will become effective on April 2, 2026, and the company’s common stock will open for trading on Nasdaq on a post-split basis on April 2, 2026, under the company’s existing trading symbol, “PSTV.”
- The reverse stock split is being implemented to increase the per share trading price of the company’s common stock for the purpose of ensuring a share price high enough to comply with the minimum $1.00 bid price requirement for continued listing on Nasdaq.
- The reverse stock split will reduce the company’s outstanding common stock from approximately 171.55M shares to about 6.86M shares.
- PSTV -12.95% premarket to $0.1868.
- Source: Press Release
More on Plus Therapeutics
- Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering - Slideshow
- Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript
- Plus Therapeutics GAAP EPS of -$0.29 beats by $0.01, revenue of $5.21M beats by $0.14M
- Plus Therapeutics stock plunges after pricing $15M units offering
- Seeking Alpha’s Quant Rating on Plus Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。